EDOG - Institut Claudius Regaud - PPDS

Toulouse, Haute-garonne 31059 Cedex 9

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, HER2-positive Breast Cancer, Melanoma and Metastatic Colorectal Cancer

Studies at this site

• A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors — Running, not enrolling
• A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma — Completed